Intravenous saline and amino acid drug supplies should begin to increase in the next few weeks as manufacturing facilities in Puerto Rico ramp up production, Food and Drug Administration Commissioner Scott Gottlieb, M.D., said yesterday in an update on the shortages. “Just before the holidays, Baxter – a leading producer of IV saline fluids – announced that all their facilities on the island have returned to the commercial power grid,” Gottlieb said. “Moreover, all the other companies that manufacture products that were on our initial list of drugs that we considered critical and at risk of potential shortages – because the drugs were largely or entirely manufactured in Puerto Rico – are now on the power grid. Many of these companies report to us that their production is increasing. While there are still many challenges that remain – for instance, the commercial power grid remains unstable in places – these developments reduce the risk of any future shortages resulting from the impact of the storm on the island’s manufacturing sector.” AHA has urged FDA and Congress to do more to address the drug shortages, and worked with FDA and the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response to update members on the issue.

Related News Articles

Headline
The AHA Quest for Quality Prize honors hospitals and health systems committed to leadership and innovation in improving quality and advancing health. Learn how…
Blog
Read about the 2025 Quest for Quality Prize winner and finalist — and apply for the 2026 awardEach day, health care professionals across the U.S. leverage…
Perspective
Public
Hospitals and health systems across the country vary in size, as well as the types of services and specialties they offer. They also offer many different…
Headline
Nell Buhlman, chief administrative officer and head of strategy at Press Ganey, and Chris DeRienzo, M.D., AHA chief physician executive, explore the data-…
Headline
The Department of Health and Human Services July 28 announced the creation of a $100 million pilot program to prevent, test for, treat and cure hepatitis C for…
Perspective
Public
The 2025 AHA Leadership Summit wrapped up on July 22, and as always, it was energizing and inspiring to connect with so many talented and dedicated people…